General Information of the Compound
Compound ID
CP0561537
Compound Name
4-[4-[(2-methylphenyl)methyl]-3-oxopiperazin-1-yl]-5-morpholin-4-yl-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C20H25N5O3
Molecular Weight
383.452
Canonical SMILES
Cc1ccccc1CN1CCN(CC1=O)c1cn[nH]c(=O)c1N1CCOCC1
    Show/Hide
InChI
InChI=1S/C20H25N5O3/c1-15-4-2-3-5-16(15)13-25-7-6-24(14-18(25)26)17-12-21-22-20(27)19(17)23-8-10-28-11-9-23/h2-5,12H,6-11,13-14H2,1H3,(H,22,27)
    Show/Hide
InChIKey
RZKOYHYHOWFDPS-UHFFFAOYSA-N
Physicochemical Property
logP
0.76372
Rotatable Bonds
4
Heavy Atom Count
28
Polar Areas
81.77
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 138483782
ChEMBL ID
CHEMBL4469449
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS